Oncology Ventures

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Enterprise software · Jan 1, 2026
Rounds participated in
4
Confirmed lead rounds
—
4 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$56.6M
4 disclosed · full round size, not this investor’s share

By stage

Series A2
Series B1
Undisclosed1

By primary sector

Healthtech3
AI1

By country

United States4

Rounds

4 in this selection
Triomics

Building AI infrastructure to turn complex cancer records into structured intelligence

$22MSeries B
Role not disclosed
Modicus Prime

Builds AI compliance software enabling audit-ready AI deployment for pharmaceutical and regulated industries

$4.5MUndisclosed
Role not disclosed
NexCure

Provides CAR-T and other advanced treatment delivery in community outpatient settings

$19MSeries A
Role not disclosed
RISA Labs

Develops AI operating system for oncology workflows

$11.1MSeries A
Role not disclosed